0001144204-16-095369.txt : 20160420 0001144204-16-095369.hdr.sgml : 20160420 20160420180019 ACCESSION NUMBER: 0001144204-16-095369 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20151231 FILED AS OF DATE: 20160420 DATE AS OF CHANGE: 20160420 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ReWalk Robotics Ltd. CENTRAL INDEX KEY: 0001607962 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6 STREET 2: P.O. BOX 161 CITY: YOKNEAM ILIT STATE: L3 ZIP: 20692 BUSINESS PHONE: 97249590123 MAIL ADDRESS: STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6 STREET 2: P.O. BOX 161 CITY: YOKNEAM ILIT STATE: L3 ZIP: 20692 FORMER COMPANY: FORMER CONFORMED NAME: Argo Medical Technologies Ltd. DATE OF NAME CHANGE: 20140513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Disanzo Deborah CENTRAL INDEX KEY: 0001661251 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-36612 FILM NUMBER: 161582181 MAIL ADDRESS: STREET 1: KOCHAV YOKNEAM BUILDING, FLOOR 6 STREET 2: P.O. BOX 161 CITY: YOKNEAM ILIT STATE: L3 ZIP: 20692 3/A 1 v437120_3a.xml OWNERSHIP DOCUMENT X0206 3/A 2015-12-31 2015-12-31 0 0001607962 ReWalk Robotics Ltd. RWLK 0001661251 Disanzo Deborah C/O REWALK ROBOTICS LTD. 3 HATNUFA ST., P.O. BOX 161 YOKNEAM ILIT L3 20692203 ISRAEL 1 0 0 0 Option (Right to buy) 7.3 2025-12-03 Ordinary Shares 4176 D Option (Right to buy) 9.21 2025-09-16 Ordinary Shares 12546 D Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on December 3, 2015. The options become vested and exercisable in 12 equal quarterly installments starting three months following the date of grant. The Reporting Person is amending the Form 3 filed on December 31, 2015 to clarify the terms of the vesting schedule of the stock options to purchase 4,176 Ordinary Shares reported therein. Represents stock options granted under the ReWalk 2014 Equity Incentive Plan on September 16, 2015. The options become vested and exercisable in 12 equal quarterly installments starting three months following the date of grant. The Reporting Person is amending the Form 3 filed on December 31, 2015 to clarify the terms of the vesting schedule of the stock options to purchase 12,546 Ordinary Shares reported therein. The exercise price of the stock options represents the higher of the fair market value of the Issuer's Ordinary Shares as of August 17, 2015 (the date that the Issuer's board of directors approved the stock option grant in connection with its approval of the Reporting Person's appointment as a director of the Issuer) and the fair market value of the Issuer's Ordinary Shares as of September 16, 2015 (the effective date of the Reporting Person's appointment as a director of the Issuer). /s/ Kevin Hershberger, as attorney-in-fact 2016-04-20